Australia - engelsk - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - human immunoglobulin g, quantity: 160 mg/ml; zoster immunoglobulin, quantity: 200 iu - injection, solution - excipient ingredients: water for injections; glycine; human immunoglobulin a - indications as at 8 august 2002 : zoster immunoglobulin is indicated for prophylaxis against varicella in patients who meet all four of the criteria listed below: 1. one of the following underlying illnesses or conditions: a. neoplastic disease (leukaemia or lymphoma); b. congenital or acquired immunodeficiency; c. immunosuppressive therapy with steroids or antimetabolites. 2. one of the following types of exposure to chickenpox or shingles patients: a. household contact; b. playmate contact (>1 hour play indoors); c. hospital contact (in same 2 to 4 bedroom or adjacent beds in a large ward); d. newborn contact (newborn of mother who had onset of chickenpox <5 days before delivery or within 48 hours after delivery); e. premature infant (>= 28 weeks gestation) whose mother lacks a prior history of chickenpox; f. premature infant (< 28 weeks gestation or <= 1000g) regardless of maternal history. 3. negative or unknown history of chickenpox. 4. if zoster immunoglobulin can be administered within 96 hours after exposure. zoster immunoglobulin, normal immunoglobulin (immunoglobulin for intramuscular use) or plasma are of no value in the treatment of established varicella or zoster infection. high levels of circulating antibody do not prevent dissemination of infection. zoster immunoglobulin is not indicated for prophylactic use in immunodeficient children or adults when there is a history of varicella, unless the patient's immunosuppressed status is that which is associated with bone marrow transplantation.

Israel - engelsk - Ministry of Health

merck serono ltd - follitropin alfa - solution for injection - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - in adult women:• anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.• stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).• follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult men:• follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratorios hipra s.a. - human chorionic gonadotrophin 1000 iu; equine serum gonadotrophin 2000 iu - lyophilisate for solution for injection - gonadotrophin serum (pmsg) 2000 iu; gonadotrophin chorionic (hch) 1000 iu - gonadotropins, combinations - pig

India - engelsk - Central Drugs Standard Control Organization

svizera - human chorionic gonadotrophin - inj - highly purified human chorionic gonadtrophin ip 10000 iu,mannitol ip 12mg,potassium dihydrogen orthophosphate bp 0.46mg,dipotass - 10000 iu

India - engelsk - Central Drugs Standard Control Organization

svizera - human chorionic gonadotrophin - inj - highly purified human chorionic gonadtrophin ip 2000 iu,mannitol ip 12mg,potassium dihydrogen orthophosphate bp 0.46mg,dipotassi - 2000 iu

India - engelsk - Central Drugs Standard Control Organization

svizera - human chorionic gonadotrophin - inj - highly purified human chorionic gonadtrophin ip 5000 iu,mannitol ip 12mg,potassium dihydrogen orthophosphate bp 0.46mg,dipotassi - 5000 iu

Irland - engelsk - HPRA (Health Products Regulatory Authority)

instituto grifols s.a. - human plasma protein - solution for infusion - 50 gram(s)/litre - blood substitutes and plasma protein fractions; albumin

Irland - engelsk - HPRA (Health Products Regulatory Authority)

instituto grifols s.a. - human albumin - solution for infusion - 200 gram(s)/litre - blood substitutes and plasma protein fractions; albumin

Singapore - engelsk - HSA (Health Sciences Authority)

takeda pharmaceuticals (asia pacific) pte. ltd. - human albumin - solution, sterile - 200 mg/ml - human albumin 200 mg/ml

Singapore - engelsk - HSA (Health Sciences Authority)

csl behring pte. ltd. - human albumin - infusion, solution - 200g/l - human albumin 200g/l